Your browser doesn't support javascript.
loading
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
Takou, Desire; Fokam, Joseph; Teto, Georges; Santoro, Maria-Mercedes; Ceccherini-Silberstein, Francesca; Nanfack, Aubin Joseph; Sosso, Samuel Martin; Dambaya, Béatrice; Salpini, Romina; Billong, Serge Clotaire; Gori, Caterina; Fokunang, Charles Ntungwen; Cappelli, Giulia; Colizzi, Vittorio; Perno, Carlo-Federico; Ndjolo, Alexis.
Afiliación
  • Takou D; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
  • Fokam J; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon. josephfokam@gmail.com.
  • Teto G; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon. josephfokam@gmail.com.
  • Santoro MM; National HIV Drug Resistance prevention and surveillance Working Group, Ministry of Public Health, Yaoundé, Cameroon. josephfokam@gmail.com.
  • Ceccherini-Silberstein F; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
  • Nanfack AJ; University of Rome Tor Vergata, Rome, Italy.
  • Sosso SM; University of Rome Tor Vergata, Rome, Italy.
  • Dambaya B; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
  • Salpini R; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
  • Billong SC; Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management, Yaoundé, Cameroon.
  • Gori C; University of Rome Tor Vergata, Rome, Italy.
  • Fokunang CN; National HIV Drug Resistance prevention and surveillance Working Group, Ministry of Public Health, Yaoundé, Cameroon.
  • Cappelli G; Surveillance, Research, Planning, Monitoring and Evaluation service, Central Technical Group, National AIDS Control Committee, Yaounde, Cameroon.
  • Colizzi V; National Institute of Infectious Diseases Lazzaro Spallanzani, Rome, Italy.
  • Perno CF; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
  • Ndjolo A; Institute of Cellular Biology and Neurobiology (IBCN), Consiglio Nazionale delle Ricerche (CNR), Rome, Italy.
BMC Infect Dis ; 19(1): 246, 2019 Mar 12.
Article en En | MEDLINE | ID: mdl-30871487
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Child / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2019 Tipo del documento: Article País de afiliación: Camerún
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Child / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2019 Tipo del documento: Article País de afiliación: Camerún